FDA calls out 'particularly concerning' claims on HCP site for Taiho's Lytgobi

In an untitled letter issued last Friday and made public this week, the FDA took aim at clinical data included on a doctor-facing webpage for Taiho Oncology’s Lytgobi.

Mar 26, 2025 - 19:13
 0
FDA calls out 'particularly concerning' claims on HCP site for Taiho's Lytgobi
In an untitled letter issued last Friday and made public this week, the FDA took aim at clinical data included on a doctor-facing webpage for Taiho Oncology’s Lytgobi.